Maximum Recommended Daily Doses for Antiseizure Medications
Based on FDA labeling and clinical guidelines, the maximum recommended daily doses in adults are: perampanel 12 mg/day, brivaracetam 200 mg/day (100 mg twice daily), lacosamide 400-600 mg/day depending on context, phenytoin 400-600 mg/day, and valproate 60 mg/kg/day.
Perampanel
- Maximum dose: 12 mg once daily at bedtime 1
- For partial-onset seizures (monotherapy or adjunctive): 12 mg/day provides greater seizure reduction than 8 mg/day but with substantially increased adverse reactions 1
- For primary generalized tonic-clonic seizures (adjunctive): 8 mg/day is the recommended maintenance dose, though patients may benefit from 12 mg/day if tolerated 1
- Hepatic impairment reduces maximum: 6 mg/day for mild impairment, 4 mg/day for moderate impairment 1
Brivaracetam
- Maximum dose: 200 mg/day (100 mg twice daily) 2
- This applies to adults and pediatric patients ≥50 kg 2
- Hepatic impairment reduces maximum to 150 mg/day (75 mg twice daily) 2
- Weight-based dosing for pediatric patients <50 kg ranges up to 4-6 mg/kg/day depending on weight category 2
Lacosamide
- Maximum dose: 400-600 mg/day depending on clinical context
- Standard maximum in monotherapy trials: 600 mg/day 3
- When used with enzyme-inducing antiepileptics, doses up to 600 mg/day have been studied, though the guideline notes that loading doses (not maximum maintenance) were the primary focus 4
- The medication is typically dosed twice daily 4
Phenytoin
- Maximum loading dose: 20 mg/kg (divided in 400 mg increments every 2 hours orally, or 18 mg/kg IV at maximum rate of 50 mg/min) 4
- Maintenance dosing typically ranges 300-400 mg/day in clinical practice, though the guidelines focus on loading strategies rather than maximum maintenance doses 4
- Fosphenytoin equivalent: 18-20 PE/kg for loading 4
Valproate
- Maximum dose: Up to 60 mg/kg/day based on clinical practice
- For status epilepticus loading: 20-30 mg/kg IV at maximum rate of 10 mg/kg/min or 40 mg/min 4
- The guidelines do not specify an absolute maximum maintenance dose, but clinical practice typically caps at 3000-4000 mg/day or 60 mg/kg/day
Important Caveats
Drug interactions significantly affect dosing requirements:
- Enzyme-inducing antiepileptics (carbamazepine, phenytoin, phenobarbital) reduce exposure to perampanel, brivaracetam, and lacosamide by 19-32% 1, 5, 6
- When starting perampanel with enzyme inducers, begin at 4 mg/day instead of 2 mg/day, with maximum studied dose of 12 mg/day 1
- Brivaracetam exposure decreases 32% with carbamazepine and 29% with phenobarbital, though dose adjustment is not formally required 2, 5
- Lacosamide clearance increases 48% with carbamazepine co-administration 6
Renal and hepatic impairment require dose reductions for most agents, particularly perampanel and brivaracetam as detailed above 1, 2.
Titration matters for safety: Perampanel requires weekly 2 mg increments to minimize psychiatric adverse effects 1. Brivaracetam does not require gradual escalation 2.